Search for:

Webmail
UCD Access
Canvas
Quick Links

School of Medicine

Home
Education

Admissions

Current Students

Academy of Medical Educators

Diversity & Inclusion

Continuing Medical Education

Contact Us
Research

Clinical Trials

Colorado Clinical & Translational Sciences Institute (CCTSI)

Research Core Labs

Health Data Compass

Information Services

Office of Grants & Contracts

Office of Laboratory Animal Resources

Regulatory Compliance

Research Affairs

Research Development

Resources for Investigators

Transformational Research Funding

Donate
Patient Care

Clinical Affairs

Advanced Practice Providers

Donate
Departments | Centers | Institutes
Dean's Office

About Us

Administrative Fellowship Program

Administrative Toolbox

Alumni

Contact Information

CU Medicine Today

Diversity & Inclusion

The Hub

Information Services

Leadership

University of Colorado Medicine

Donate
Faculty
News

Early Signals of Efficacy With Cystic Fibrosis Gene Therapy

Default sub title

minute read

by CGTLive | August 26, 2024

4D Molecular Therapeutics’ 4D-710 is an investigational gene therapy currently being evaluated for the treatment of cystic fibrosis (CF) in the phase 1/2 AEROW clinical trial (NCT05248230).

Topics: Press Coverage

Spread the word:

Related Articles

School of Medicine

CU Anschutz

Fitzsimons Building

13001 East 17th Place

Aurora, CO 80045

303.724.5375

Facebook Twitter

School

School of Medicine Home

Find a Researcher

School Profiles

General

Affiliate/Partner Hospitals

Map and Parking

Students

Health Sciences Library

Colorado Springs Branch

Contact Us
Website Feedback
CU System
Privacy Policy
Terms of Use
Accessibility
Accreditation
Employment
Give Now

© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.